Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia

Journal of the American Medical Directors Association

Volumn 18, Issue 6, 2017, Pages 551.e1-551.e7

  Morin, Lucas ^a   Vetrano, Davide L ^a,b   Grande, Giulia ^a,c   Fratiglioni, Laura ^a   Fastbom, Johan ^a   Johnell, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Dementia; drug therapy; end of life; palliative care

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CHOLINESTERASE INHIBITOR; HORMONE ANTAGONIST; IMMUNOMODULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEMANTINE; NOOTROPIC AGENT; SEX HORMONE; PRESCRIPTION DRUG;

AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DEMENTIA; DRUG EXPOSURE; FEMALE; HUMAN; LIFE EXPECTANCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION; PREVALENCE; SWEDEN; TIME OF DEATH; VERY ELDERLY; REGISTER; TERMINAL CARE; UNNECESSARY PROCEDURE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; PRESCRIPTION DRUGS; REGISTRIES; SWEDEN; TERMINAL CARE; UNNECESSARY PROCEDURES;

EID: 85017524482     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2017.02.021     Document Type: Article

References (30)

1. 1 Holmes, H.M., Sachs, G.A., Shega, J.W., et al. Integrating palliative medicine into the care of persons with advanced dementia: Identifying appropriate medication use. J Am Geriatr Soc 56 (2008), 1306–1311.
2. 2 Stevenson, J., Abernethy, A.P., Miller, C., Currow, D.C., Managing comorbidities in patients at the end of life. Br Med J 329 (2004), 909–912.
3. 3 Holmes, H.M., Hayley, D.C., Alexander, G.C., Sachs, G.A., Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166 (2006), 605–609.
4. 4 Todd, A., Husband, A., Andrew, I., et al. Inappropriate prescribing of preventative medication in patients with life-limiting illness: A systematic review. BMJ Support Palliat Care 7 (2017), 113–121.
5. 5 Currow, D.C., Stevenson, J.P., Abernethy, A.P., et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 55 (2007), 590–595.
6. 6 LeBlanc, T.W., McNeil, M.J., Kamal, A.H., et al. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol 16 (2015), e333–e341.
7. 7 Tjia, J., Cutrona, S.L., Peterson, D., et al. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc 62 (2014), 2095–2101.
8. 8 McNeil, M.J., Kamal, A.H., Kutner, J.S., et al. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage 51 (2016), 178–183.e2.
9. 9 Lau, H.S., De Boer, A., Beuning, K.S., Porsius, A., Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50 (1997), 619–625.
10. 10 Johnell, K., Fastbom, J., Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging 29 (2012), 751–758.
11. 11 Calderón-Larrañaga, A., Vetrano, D.L., Onder, G., et al. Assessing and measuring chronic multimorbidity in the older population: A proposal for its operationalization. J Gerontol A Biol Sci Med Sci, 2016 Dec 21 [Epub ahead of print].
12. 12 Tjia, J., Briesacher, B.A., Peterson, D., et al. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med 174 (2014), 1763–1771.
13. 13 Colloca, G., Tosato, M., Vetrano, D.L., et al. Inappropriate drugs in elderly patients with severe cognitive impairment: Results from the shelter study. PLoS One, 7, 2012, e46669.
14. 14 Hanlon, J.T., Aspinall, S.L., Handler, S.M., et al. Potentially suboptimal prescribing for older veteran nursing home patients with dementia. Ann Pharmacother 49 (2015), 20–28.
15. 15 González-Colaço Harmand, M., Meillon, C., Rullier, L., et al. Cognitive decline after entering a nursing home: A 22-year follow-up study of institutionalized and noninstitutionalized elderly people. J Am Med Dir Assoc 15 (2014), 504–508.
16. 16 van Soest-Poortvliet, M.C., van der Steen, J.T., de Vet, H.C., et al. Factors related to establishing a comfort care goal in nursing home patients with dementia: A cohort study among family and professional caregivers. J Palliat Med 17 (2014), 1317–1327.
17. 17 Tan, C.-C., Yu, J.-T., Wang, H.-F., et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis 41 (2014), 615–631.
18. 18 Parsons, C., Withdrawal of antidementia drugs in older people: Who, when and how?. Drugs Aging 33 (2016), 545–556.
19. 19 Ailabouni, N.J., Nishtala, P.S., Mangin, D., Tordoff, J.M., Challenges and enablers of deprescribing: A general practitioner perspective. PLoS One, 11, 2016, e0151066.
20. 20 Todd, A., Holmes, H.M., Recommendations to support deprescribing medications late in life. Int J Clin Pharm 37 (2015), 678–681.
21. 21 Howard, R., McShane, R., Lindesay, J., et al. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: Secondary and post-hoc analyses. Lancet Neurol 4422 (2015), 1–11.
22. 22 Parsons, C., Hughes, C.M., Passmore, A.P., Lapane, K.L., Withholding, discontinuing and withdrawing medications in dementia patients at the end of life. Drugs Aging 27 (2010), 435–449.
23. 23 O'Regan, J., Lanctot, K.L., Mazereeuw, G., Herrmann, N., Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: A meta-analysis of randomized controlled trials. J Clin Psychiatry 76 (2015), e1424–e1431.
24. 24 Mitchell, S.L., Miller, S.C., Teno, J.M., et al. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA 304 (2010), 1929–1935.
25. 25 Brown, M.A., Sampson, E.L., Jones, L., Barron, A.M., Prognostic indicators of 6-month mortality in elderly people with advanced dementia: A systematic review. Palliat Med 27 (2013), 389–400.
26. 26 Mitchell, S.L., Teno, J.M., Kiely, D.K., et al. The clinical course of advanced dementia. N Engl J Med 361 (2009), 1529–1538.
27. 27 Sachs, G.G.A., Shega, J.W., Cox-Hayley, D., Barriers to excellent end-of-life care for patients with dementia. J Gen Intern Med 19 (2004), 1057–1063.
28. 28 White, N., Reid, F., Harris, A., et al. A systematic review of predictions of survival in palliative care: How accurate are clinicians and who are the experts?. PLoS One, 11, 2016, e0161407.
29. 29 Casarett, D.J., Farrington, S., Craig, T., et al. The art versus science of predicting prognosis: Can a prognostic index predict short-term mortality better than experienced nurses do?. J Palliat Med 15 (2012), 703–708.
30. 30 van Riet Paap, J., Mariani, E., Chattat, R., et al. Identification of the palliative phase in people with dementia: A variety of opinions between healthcare professionals. BMC Palliat Care, 14, 2015, 56.